Not IonQ. Not Rigetti. This Quantum Computing Stock Could Be the Next to Soar.
D-Wave Quantum (QBTS) is gaining attention for its quantum annealing technology, with growing commercial adoption and partnerships. The company expects to release Q3 earnings on Nov. 10. D-Wave has secured $100M in U.S. government funding and partnerships with LG CNS and SkyWater Technology. Analysts rate it a buy with an average target price of $35, suggesting 225% upside potential.
How this was made
The 30-second read
Why it matters
For traders, the main decision point is the upcoming Q3 earnings release date, while the cited CHIPS funding, LG CNS relationship, and SkyWater manufacturing agreement provide longer-horizon support for the thesis.
Market read
A quantum-hardware bullish setup for QBTS, anchored by a scheduled earnings catalyst and supported by funding and partnership announcements.
What to watch
Key risks are roadmap slippage and commercialization timing; without fresh guidance or earnings datapoints, the market may treat these as incremental rather than re-rating catalysts.
Background
The article positions D-Wave as a quantum annealing alternative and contrasts it with IonQ and Rigetti, emphasizing commercialization, partnerships, and government support.
Ticker impact
D-Wave (QBTS) is highlighted for stronger demand, a Nov. 10 Q3 earnings release, and new partnerships plus CHIPS funding and SkyWater manufacturing agreement.
Likely upward tilt as investors price in commercialization momentum and government support, with volatility around the Nov. 10 earnings catalyst.
The article cites multiple concrete catalysts (CHIPS and Science Act funding up to $100M, LG CNS relationship, SkyWater multi-year manufacturing agreement) but provides no new financial results; the most actionable near-term event is the scheduled Q3 earnings release.
Market effects
Reinforces the quantum annealing commercialization theme versus gate-based peers, potentially supporting broader sentiment toward quantum hardware/software enablers.
US-listed quantum names may see sentiment spillover from CHIPS-related support and enterprise partnership headlines.
US government funding and cross-border enterprise partnerships (LG CNS, Japanese research example) underscore global commercialization efforts in quantum.
Counterpoint
The piece is largely a promotional framing around adoption and partnerships, with no new quarterly numbers; high P/S implies expectations are already elevated and execution risk remains high.
Key entities
- companyD-Wave Quantum
Quantum annealing provider discussed as seeing stronger demand and expanding partnerships.
- governmentU.S. Department of Commerce
Agreed to provide up to $100 million funding under the CHIPS and Science Act.
- companyLG CNS
Enterprise technology partner for developing applications using D-Wave quantum technology.
- companySkyWater Technology
Manufacturing partner for semiconductor processes for D-Wave quantum systems.
- companyShionogi
Japanese pharmaceutical example using quantum-assisted drug discovery research involving D-Wave technology.
